Bio-Techne Corp Profit Margin 2006-2021 | TECH
Current and historical gross margin, operating margin and net profit margin for Bio-Techne Corp (TECH) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Bio-Techne Corp net profit margin as of September 30, 2021 is 17.94%.
|Bio-Techne Corp Annual Profit Margins
|Bio-Techne Corp Quarterly Profit Margins
||Medical - Biomedical and Genetics
Bio-Techne Corporation is a global life sciences company. It develops, manufactures, and sells biotechnology products and clinical diagnostic controls. It provides proteins, such as cytokines, growth factors, and enzymes; antibodies, including polyclonal and monoclonal antibodies; immunoassays comprising quantikine kits; and clinical diagnostic immunoassay kits. The Company also offers flow cytometry products; natural and synthetic chemical compounds; hematology controls and calibrators; and hematology control products. Bio-Techne Corporation, formerly known as Techne Corporation, is headquartered in Minneapolis, Minnesota.